CROBM CROBM & JDR Merger
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trackman, P. C.
Right arrow Articles by Kantarci, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trackman, P. C.
Right arrow Articles by Kantarci, A.
15(3):165-175 (2004)     Crit Rev Oral Biol Med
© 2004 International and American Associations for Dental Research

CONNECTIVE TISSUE METABOLISM AND GINGIVAL OVERGROWTH

P. C. Trackman*
A. Kantarci

Boston University Goldman School of Dental Medicine, Department of Periodontology and Oral Biology, Division of Oral Biology, 700 Albany Street, W-210, Boston, MA 02118;

* corresponding author, trackman{at}bu.edu

Gingival overgrowth occurs mainly as a result of certain anti-seizure, immunosuppressive, or antihypertensive drug therapies. Excess gingival tissues impede oral function and are disfiguring. Effective oral hygiene is compromised in the presence of gingival overgrowth, and it is now recognized that this may have negative implications for the systemic health of affected patients. Recent studies indicate that cytokine balances are abnormal in drug-induced forms of gingival overgrowth. Data supporting molecular and cellular characteristics that distinguish different forms of gingival overgrowth are summarized, and aspects of gingival fibroblast extracellular matrix metabolism that are unique to gingival tissues and cells are reviewed. Abnormal cytokine balances derived principally from lymphocytes and macrophages, and unique aspects of gingival extracellular matrix metabolism, are elements of a working model presented to facilitate our gaining a better understanding of mechanisms and of the tissue specificity of gingival overgrowth.

Key words. Gingival overgrowth, gingival hyperplasia, growth factors, cytokines, connective tissue, connective tissue growth factor, fibrosis




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
A. Kantarci, P. Augustin, E. Firatli, M.C. Sheff, H. Hasturk, D.T. Graves, and P.C. Trackman
Apoptosis in Gingival Overgrowth Tissues
J. Dent. Res., September 1, 2007; 86(9): 888 - 892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Black Jr., A. H. Palamakumbura, M. Stan, and P. C. Trackman
Tissue-specific Mechanisms for CCN2/CTGF Persistence in Fibrotic Gingiva: INTERACTIONS BETWEEN cAMP AND MAPK SIGNALING PATHWAYS, AND PROSTAGLANDIN E2-EP3 RECEPTOR MEDIATED ACTIVATION OF THE c-JUN N-TERMINAL KINASE
J. Biol. Chem., May 25, 2007; 282(21): 15416 - 15429.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
L. Hakkinen and A. Csiszar
Hereditary Gingival Fibromatosis: Characteristics and Novel Putative Pathogenic Mechanisms
J. Dent. Res., January 1, 2007; 86(1): 25 - 34.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2004 Institutional Access Guidelines